Green Thumb Industries Inc. (GTBIF)
OTCMKTS · Delayed Price · Currency is USD
8.10
-0.12 (-1.46%)
At close: Jan 9, 2026
Green Thumb Industries Revenue
Green Thumb Industries had revenue of $291.37M in the quarter ending September 30, 2025, with 1.57% growth. This brings the company's revenue in the last twelve months to $1.16B, up 3.34% year-over-year. In the year 2024, Green Thumb Industries had annual revenue of $1.14B with 7.83% growth.
Revenue (ttm)
1.16B
Revenue Growth
+3.34%
P/S Ratio
1.62
Revenue / Employee
241.35K
Employees
4,800
Market Cap
1.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.14B | 82.59M | 7.83% |
| Dec 31, 2023 | 1.05B | 37.18M | 3.65% |
| Dec 31, 2022 | 1.02B | 123.82M | 13.86% |
| Dec 31, 2021 | 893.56M | 336.99M | 60.55% |
| Dec 31, 2020 | 556.57M | 340.14M | 157.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Green Thumb Industries News
- 4 days ago - Top 3 Marijuana Stocks To Buy While Things Are Getting Started In 2026 - MarijuanaStocks
- 6 days ago - 5 Predictions for the Stock Market in 2026 -- and Which Stocks Will Soar the Most If They're Right - The Motley Fool
- 12 days ago - 2 Marijuana Stocks To Watch For Better Investing In 2026 - MarijuanaStocks
- 17 days ago - Should You Buy GTBIF Stock After Marijuana Reclassification Order? - Nasdaq
- 18 days ago - President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys? - The Motley Fool
- 18 days ago - 3 Top Marijuana Stocks After Cannabis Gets Rescheduled - MarijuanaStocks
- 22 days ago - Cannabis Investing In The Trump Era - Seeking Alpha
- 23 days ago - Why I Am Downgrading Green Thumb Industries - Seeking Alpha